Literature DB >> 32843460

Compound heterozygous mutations in KCNJ2 and KCNH2 in a patient with severe Andersen-Tawil syndrome.

Margarita E Polyak1, Anna Shestak2, Dmitriy Podolyak3, Elena Zaklyazminskaya2.   

Abstract

Andersen-Tawil syndrome (ATS) is a rare channelopathy, sometimes referred to as long QT syndrome type 7. ATS is an autosomal dominant disease predominantly caused by mutations in the KCNJ2 gene. Patients with ATS present with episodes of muscle weakness, arrythmias, including prolonged QT intervals, and various skeletal abnormalities. Unlike other channelopathies, ATS has a relatively mild clinical course and low risk of sudden cardiac death. In this study, we describe a female patient with typical symptoms of ATS with the addition of unusually severe arrhythmias. Extensive DNA testing was performed to find the possible cause of this unique presentation. In addition to a known mutation in KCNJ2, the patient carried a variant in KCNH2 The combination of genetic variants may lead to the severe clinical manifestation of ATS. Additional genetic information allowed accurate genetic counselling to be provided to the patient. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  arrhythmias; cardiovascular system; genetic screening / counselling

Mesh:

Substances:

Year:  2020        PMID: 32843460      PMCID: PMC7449271          DOI: 10.1136/bcr-2020-235703

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Genotype-phenotype correlations of KCNJ2 mutations in Japanese patients with Andersen-Tawil syndrome.

Authors:  Yoshisumi Haruna; Atsushi Kobori; Takeru Makiyama; Hidetada Yoshida; Masaharu Akao; Takahiro Doi; Keiko Tsuji; Seiko Ono; Yukiko Nishio; Wataru Shimizu; Takehiko Inoue; Tomoaki Murakami; Naoya Tsuboi; Hideo Yamanouchi; Hiroya Ushinohama; Yoshihide Nakamura; Masao Yoshinaga; Hitoshi Horigome; Yoshifusa Aizawa; Toru Kita; Minoru Horie
Journal:  Hum Mutat       Date:  2007-02       Impact factor: 4.878

2.  Review of Cardiovascular Drugs in Pregnancy.

Authors:  Aaron B Kaye; Amar Bhakta; Alex D Moseley; Anupama K Rao; Sally Arif; Seth J Lichtenstein; Neelum T Aggarwal; Annabelle S Volgman; Rupa M Sanghani
Journal:  J Womens Health (Larchmt)       Date:  2018-11-08       Impact factor: 2.681

Review 3.  2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Authors:  Sana M Al-Khatib; William G Stevenson; Michael J Ackerman; William J Bryant; David J Callans; Anne B Curtis; Barbara J Deal; Timm Dickfeld; Michael E Field; Gregg C Fonarow; Anne M Gillis; Christopher B Granger; Stephen C Hammill; Mark A Hlatky; José A Joglar; G Neal Kay; Daniel D Matlock; Robert J Myerburg; Richard L Page
Journal:  Heart Rhythm       Date:  2017-10-30       Impact factor: 6.343

4.  A novel neuropsychiatric phenotype of KCNJ2 mutation in one Taiwanese family with Andersen-Tawil syndrome.

Authors:  Hoi-Fong Chan; Meng-Ling Chen; Jen-Jen Su; Li-Chin Ko; Chin-Hsien Lin; Ruey-Meei Wu
Journal:  J Hum Genet       Date:  2010-01-29       Impact factor: 3.172

5.  Intrafamilial phenotypic variability in Andersen-Tawil syndrome: A diagnostic challenge in a potentially treatable condition.

Authors:  A Ardissone; V Sansone; L Colleoni; P Bernasconi; I Moroni
Journal:  Neuromuscul Disord       Date:  2016-11-18       Impact factor: 4.296

6.  Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations.

Authors:  Koji Miyamoto; Takeshi Aiba; Hiromi Kimura; Hideki Hayashi; Seiko Ohno; Chie Yasuoka; Yoshihito Tanioka; Takeshi Tsuchiya; Yoko Yoshida; Hiroshi Hayashi; Ippei Tsuboi; Ikutaro Nakajima; Kohei Ishibashi; Hideo Okamura; Takashi Noda; Masaharu Ishihara; Toshihisa Anzai; Satoshi Yasuda; Yoshihiro Miyamoto; Shiro Kamakura; Kengo Kusano; Hisao Ogawa; Minoru Horie; Wataru Shimizu
Journal:  Heart Rhythm       Date:  2014-12-10       Impact factor: 6.343

7.  Novel mutation in the KCNJ2 gene is associated with a malignant arrhythmic phenotype of Andersen-Tawil syndrome.

Authors:  E Fernlund; C Lundin; E Hertervig; O Kongstad; M Alders; P Platonov
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-09       Impact factor: 1.468

8.  2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).

Authors:  Silvia G Priori; Carina Blomström-Lundqvist; Andrea Mazzanti; Nico Blom; Martin Borggrefe; John Camm; Perry Mark Elliott; Donna Fitzsimons; Robert Hatala; Gerhard Hindricks; Paulus Kirchhof; Keld Kjeldsen; Karl-Heinz Kuck; Antonio Hernandez-Madrid; Nikolaos Nikolaou; Tone M Norekvål; Christian Spaulding; Dirk J Van Veldhuisen
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

9.  Reduction of complex ventricular ectopy and improvement in exercise capacity with flecainide therapy in Andersen-Tawil syndrome.

Authors:  David J Fox; George J Klein; Angelika Hahn; Allan C Skanes; Lorne J Gula; Raymond K Yee; Rajesh N Subbiah; Andrew D Krahn
Journal:  Europace       Date:  2008-07-11       Impact factor: 5.214

10.  Variable penetrance of Andersen-Tawil syndrome in a family with a rare missense KCNJ2 mutation.

Authors:  Reem Deeb; Aravindhan Veerapandiyan; Rabi Tawil; Simona Treidler
Journal:  Neurol Genet       Date:  2018-10-25
View more
  1 in total

1.  Variable Clinical Appearance of the Kir2.1 Rare Variants in Russian Patients with Long QT Syndrome.

Authors:  Elena Zaklyazminskaya; Margarita Polyak; Anna Shestak; Mariam Sadekova; Vera Komoliatova; Irina Kiseleva; Leonid Makarov; Dmitriy Podolyak; Grigory Glukhov; Han Zhang; Denis Abramochkin; Olga S Sokolova
Journal:  Genes (Basel)       Date:  2022-03-22       Impact factor: 4.141

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.